211 related articles for article (PubMed ID: 27166797)
1. Obesity and Cardiovascular Risk: Variations in Visfatin Gene Can Modify the Obesity Associated Cardiovascular Risk. Results from the Segovia Population Based-Study. Spain.
Martínez Larrad MT; Corbatón Anchuelo A; Fernández Pérez C; Pérez Barba M; Lazcano Redondo Y; Serrano Ríos M;
PLoS One; 2016; 11(5):e0153976. PubMed ID: 27166797
[TBL] [Abstract][Full Text] [Related]
2. Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children.
Ooi SQ; Chan RM; Poh LK; Loke KY; Heng CK; Chan YH; Gan SU; Lee KO; Lee YS
Pediatr Obes; 2014 Apr; 9(2):81-91. PubMed ID: 23447513
[TBL] [Abstract][Full Text] [Related]
3. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans.
Böttcher Y; Teupser D; Enigk B; Berndt J; Klöting N; Schön MR; Thiery J; Blüher M; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Jul; 91(7):2725-31. PubMed ID: 16636125
[TBL] [Abstract][Full Text] [Related]
5. Association of the + 45T>G adiponectin gene polymorphism with insulin resistance in non-diabetic Saudi women.
Mackawy AM
Gene; 2013 Nov; 530(1):158-63. PubMed ID: 23958652
[TBL] [Abstract][Full Text] [Related]
6. The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity.
Belo VA; Luizon MR; Lacchini R; Miranda JA; Lanna CM; Souza-Costa DC; Tanus-Santos JE
Int J Obes (Lond); 2015 Jan; 39(1):130-5. PubMed ID: 24100423
[TBL] [Abstract][Full Text] [Related]
7. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
8. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
[TBL] [Abstract][Full Text] [Related]
9. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population.
Jian WX; Luo TH; Gu YY; Zhang HL; Zheng S; Dai M; Han JF; Zhao Y; Li G; Luo M
Diabet Med; 2006 Sep; 23(9):967-73. PubMed ID: 16922702
[TBL] [Abstract][Full Text] [Related]
10. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
Zhang XJ; Wang Z; Li HH; Yu L; Gao S
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
[TBL] [Abstract][Full Text] [Related]
11. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients.
Mirzaei K; Hossein-Nezhad A; Javad Hosseinzadeh-Attar M; Jafari N; Najmafshar A; Mohammadzadeh N; Larijani B
Minerva Endocrinol; 2009 Dec; 34(4):273-9. PubMed ID: 20046156
[TBL] [Abstract][Full Text] [Related]
12. Serum visfatin levels in a group of Egyptian obese individuals.
Reda R; Shehab A; Soliman D; Gabr A; Abbass A
Egypt J Immunol; 2011; 18(1):25-32. PubMed ID: 23082477
[TBL] [Abstract][Full Text] [Related]
13. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
[TBL] [Abstract][Full Text] [Related]
14. The glutamine 27 glutamic acid polymorphism of the beta2-adrenoceptor gene is associated with abdominal obesity and greater risk of impaired glucose tolerance in men but not in women: a population-based study in Spain.
González Sánchez JL; Proenza AM; Martínez Larrad MT; Ramis JM; Fernández Pérez C; Palou A; Serrano Ríos M
Clin Endocrinol (Oxf); 2003 Oct; 59(4):476-81. PubMed ID: 14510910
[TBL] [Abstract][Full Text] [Related]
15. Association of genetic variability in selected regions in visfatin (NAMPT) gene with anthropometric parameters and dietary composition in obese and non-obese Central-European population.
Stastny J; Bienertova-Vasku J; Tomandl J; Tomandlova M; Zlamal F; Forejt M; Splichal Z; Vasku A
Diabetes Metab Syndr; 2013; 7(3):166-71. PubMed ID: 23953183
[TBL] [Abstract][Full Text] [Related]
16. Visfatin and SREBP-1c mRNA Expressions and Serum Levels Among Egyptian Women with Polycystic Ovary Syndrome.
Abdul-Maksoud RS; Zidan HE; Saleh HS; Amer SA
Genet Test Mol Biomarkers; 2020 Jul; 24(7):409-419. PubMed ID: 32460545
[No Abstract] [Full Text] [Related]
17. Dietary fat intake associated with bone mineral density among visfatin genotype in obese people.
Khorrami-Nezhad L; Mirzaei K; Maghbooli Z; Keshavarz SA
Br J Nutr; 2018 Jan; 119(1):3-11. PubMed ID: 29355093
[TBL] [Abstract][Full Text] [Related]
18. Elevated visfatin levels in obese children are related to proinflammatory factors.
Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
[TBL] [Abstract][Full Text] [Related]
19. Serum visfatin levels in women with polycystic ovary syndrome.
Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
[TBL] [Abstract][Full Text] [Related]
20. C358A missense polymorphism of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) and visfatin levels in obese females.
de Luis DA; Gonzalez Sagrado M; Aller R; Izaola O; Conde R; Romero E
Int J Obes (Lond); 2010 Mar; 34(3):511-5. PubMed ID: 20065978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
